• Publications
  • Influence
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.
The updated version of 2009 European Association of Urology guidelines on ED and PE are presented to present, summarising the present information onED and PE. Expand
European Association of Urology guidelines on priapism.
Treatment for ischaemic priapism must be prompt in order to avoid the risk of permanent erectile dysfunction and selective embolization is the suggested treatment modality and has high success rates. Expand
EAU guidelines on penile curvature.
These European Association of Urology (EAU) guidelines summarise the present information on penile curvature and provide clinical guidelines on the diagnosis and treatment of penILE curvature. Expand
Medical students' attitudes toward patient‐centred care: a longitudinal survey
This longitudinal study aimed to assess possible attitude changes towards patient‐centredness in a medical students' cohort as they progressed through the clinical curriculum and the possible impact of socio‐demographic factors on students' attitudes. Expand
Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
PDE5 inhibitors remain a first-line treatment option because of their excellent efficacy and safety profile and intraurethral and topical alprostadil provide an alternative, less invasive treatment option. Expand
A Comparative Review of the Options for Treatment of Erectile Dysfunction
A MEDLINE search was undertaken in order to evaluate all currently available data on treatment modalities for ED, finding no data supporting superiority for any one of them in terms of efficacy or safety. Expand
Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.
PDE5-Is are efficacious and safe in young patients with normal preoperative erectile function who have undergone bilateral nerve-sparing radical prostatectomy and on-demand use of a PDE5-I may be at least as efficacious as daily use. Expand
Management strategy for arterial priapism: therapeutic dilemmas.
PURPOSE We present 7 cases of arterial high flow priapism and propose management algorithms for the condition. MATERIALS AND METHODS We studied 2 children and 5 adults with posttraumatic arterialExpand
Psychiatric morbidity is frequently undetected in patients with erectile dysfunction.
Psychiatric morbidity is highly prevalent in patients with ED, potentially affecting treatment outcome and partner support appeared to have a significant role in the patient psychological state. Expand
Pharmacotherapy for erectile dysfunction.
PDE5 inhibitors are effective, safe, and well-tolerated therapies for the treatment of men with erectile dysfunction, and Apomorphine, intracavernosal injection therapy with alprostadil, and intraurethral al Prostadil are all effective andWell-Tolerated treatments for men with erection problems. Expand